In this regard, very recently, the 11BHSD1 inhibitor S-707106 was found to be an effective insulin sensitizer, anti-sarcopenic and anti-obesity drug for patients with Cushing’s syndrome and mHC [113]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.